Novavax Aktie
7,06
EUR
+0,04
EUR
+0,53
%
7,68
USD
+0,08
USD
+0,99
%
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 6 | 3 | 0 | 139,58 GBP | - |
| Bayer | 1 | 8 | 0 | 24,88 EUR | +6,74% |
| BioNTech (ADRs) | 4 | 2 | 0 | 131,67 USD | +30,83% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 3 | 5 | 2 | 45,17 EUR | +0,40% |
| Fresenius SE & Co. KGaA (St.) | 8 | 1 | 0 | 43,86 EUR | +10,31% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Inovio Pharmaceuticals Inc | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +97,04% |
| Novartis AG | 3 | 5 | 1 | 99,12 CHF | +0,13% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 3 | 0 | 30,20 USD | +15,53% |
| Roche AG (Genussschein) | 3 | 3 | 3 | 285,88 CHF | -7,12% |
| Sanofi S.A. | 6 | 3 | 0 | 115,50 EUR | +10,80% |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |